Acute tumor lysis syndrome during oral fludarabine treatment for chronic lymphocytic leukemia. Role of treatment with rasburicase

Onkologie

Volumn 31, Issue 4, 2008, Pages 197-199

  Calvo Villas, Jose Manuel ^a   Urcuyo, Basilio Martín ^a   Umpierrez, Adelaida Morales ^a   Sicilia, Francisco ^a  

^a HOSPITAL GENERAL DE LANZAROTE   (Spain)

Author keywords

Chronic lymphocytic leukemia; Fludarabine, oral; Rasburicase; Renal failure, acute; Tumor lysis syndrome, acute

Indexed keywords

ALLOPURINOL; FLUDARABINE; RASBURICASE;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; BLOOD CHEMISTRY; CANCER STAGING; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; CONVALESCENCE; DISEASE ASSOCIATION; HEMODIALYSIS; HUMAN; HYPERKALEMIA; HYPERPHOSPHATEMIA; HYPERURICEMIA; HYPOCALCEMIA; LABORATORY TEST; MALE; MULTIPLE CYCLE TREATMENT; PHYSICAL EXAMINATION; TREATMENT OUTCOME; TUMOR LYSIS SYNDROME; URINALYSIS;

ADMINISTRATION, ORAL; AGED; ANTINEOPLASTIC AGENTS; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; TREATMENT OUTCOME; TUMOR LYSIS SYNDROME; URATE OXIDASE; VIDARABINE;

EID: 43949112294     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000118524     Document Type: Article

References (15)

1. Elter T, Hallek M, Engert A: Fludarabine in chronic lymphocytic leukaemia. Expert Opin Pharmacother 2006;7:1641-1651.
2. Robak T, Korycka A, Kasznicki M, Wrzesien-Kus A, Smolewski P: Purine nucleoside analogues for the treatment of hematological malignancies: pharmacology and clinical applications. Curr Cancer Drug Targets 2005;5:421-444.
3. Plosker GL, Figgitt DP: Oral fludarabine. Drugs 2003;63:2317-2323.
4. Cheson BD, Frame JN, Vena D, Quashu N, Sorensen JM: Tumor lysis syndrome: an uncommon complication of fludarabine therapy of chronic lymphocytic leukemia. J Clin Oncol 1998;16:2313-2320.
5. Hussain K, Mazza JJ, Clouse LH: Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): case report and review of the literature. Am J Hematol 2003;72:212-215.
6. Ramachandran A, Majumdar G: Acute tumour lysis syndrome after oral fludarabine in a patient with chronic lymphocytic leukaemia. Hematol J 2004;5:528-529.
7. Cairo MS, Bishop M: Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 2004;127:3-11.
8. List AF, Kummet TD, Adams JD, Chun HG: Tumor lysis syndrome complicating treatment of chronic lymphocytic leukemia with fludarabine phosphate. Am J Med 1990;89:388-390.
9. Killick S, Mercieca J, Nandi A, Behrens J: Fludarabine-induced tumour lysis in low-grade non-Hodgkin's lymphoma. Clin Lab Haematol 1997;19:79-80.
10. Coiffier B, Riouffol C: Management of tumor lysis syndrome in adults. Expert Rev Anticancer Ther 2007;7:233-239.
11. Frame JN, Dahut WL, Crowley S: Fludarabine and acute tumor lysis in chronic lymphocytic leukemia. N Engl J Med 1992;327:1396-1397.
12. Nakhoul F, Green J, Abassi ZA, Carter A: Tumor lysis syndrome induced by fludarabine monophosphate: a case report. Eur J Haematol 1996;56:254-255.
13. Mulligan SP, Dean MG: Fludarabine causing tumour lysis syndrome in chronic lymphocytic leukaemia. Aust N Z J Med 1994;24:406-407.
14. Hutcherson DA, Gammon DC, Bhatt MS, Faneuf M: Reduced-dose rasburicase in the treatment of adults with hyperuricemia associated with malignancy. Pharmacotherapy 2006;26:242-247.
15. Hummel M, Buchheidt D, Reiter S, Bergmann J, Adam K, Hehlmann R: Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase. Eur J Haematol 2005;75:518-521.